U.S. Markets closed

Rockwell Medical, Inc. (RMTI)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
8.52+0.27 (+3.27%)
At close: 4:00PM EDT
People also watch
RPTPRPRXHALOOMERFOLD

Rockwell Medical, Inc.

30142 Wixom Road
Wixom, MI 48393
United States
248-960-9009
http://www.rockwellmed.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees300

Key Executives

NameTitlePayExercisedAge
Mr. Robert L. ChioiniFounder, Chairman & Chief Exec. Officer1.68MN/A52
Mr. Thomas E. Klema CPA, MBAChief Financial Officer, VP of Fin., Treasurer and Sec.583.78kN/A63
Dr. Ajay Gupta M.D.Chief Scientific Officer and Member of Scientific Advisory Board633.02kN/A59
Dr. Raymond Dennis Pratt M.D., FACPChief Medical Officer597.58kN/A66
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease, iron deficiency, secondary hyperparathyroidism, and hemodialysis. The company’s lead drug is Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment via dialysate. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company’s targets customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

Corporate Governance

Rockwell Medical, Inc.’s ISS Governance QualityScore as of June 2, 2017 is 6. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 4; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.